A new player on the psoriasis block: IL-17A- and IL-22-producing innate lymphoid cells

Journal of Investigative Dermatology

Volumn 134, Issue 9, 2014, Pages 2305-2307

  Ward, Nicole L ^a   Umetsu, Dale T ^b  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b GENENTECH INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 22; INTERLEUKIN 23; TUMOR NECROSIS FACTOR ALPHA; ADALIMUMAB; ETANERCEPT; TUMOR NECROSIS FACTOR ALPHA ANTIBODY; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 2; NCR2 PROTEIN, HUMAN;

AGED; ANTIGEN SPECIFICITY; ASTHMA; ATOPIC DERMATITIS; CELL POPULATION; CROHN DISEASE; DISEASE SEVERITY; HELMINTHIASIS; HUMAN; IMMUNE DYSREGULATION; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; INFLAMMATORY BOWEL DISEASE; INNATE IMMUNITY; INNATE LYMPHOID CELL; LYMPHOID CELL; MEMORY T LYMPHOCYTE; PATHOGENESIS; PRIORITY JOURNAL; PSORIASIS; REMISSION; REVIEW; STREPTOCOCCUS INFECTION; CELL ACTIVATION; CELL DIFFERENTIATION; DERMATITIS; NONHUMAN; PSORIASIS AREA AND SEVERITY INDEX; DERMIS; EPIDERMIS; IMMUNOLOGY; LYMPHOCYTE;

DERMIS; EPIDERMIS; HUMANS; LYMPHOCYTES; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 2; PSORIASIS;

EID: 84906215927     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2014.216     Document Type: Note

References (14)

1. Bernink JH, Peters CP, Munneke M, et al. (2013). Human type 1 innate lymphoid cells accumulate in inflamed mucosal tissues. Nat Immunol 14:221-9
2. Chang Y-J, Kim H, Albacker L, et al. (2011). Innate lymphoid cells mediate influenza-induced airway hyperreactivity independent of adaptive immunity. Nat Immunol 12:631-8
3. Coccia M, Harrison OJ, Schiering C, et al. (2012). IL-1beta mediates chronic intestinal inflammation by promoting the accumulation of IL-17A secreting innate lymphoid cells and CD4(+) Th17 cells. J Exp Med 209:1595-609
4. Gudjonsson JE, Thorarinsson AM, Sigurgeirsson B, et al. (2003). Streptococcal throat infections and exacerbation of chronic plaque psoriasis: A prospective study. Br J Dermatol 149:530-4
5. Hedrick MN, Lonsdorf AS, Shirakawa AK et al. (2009) CCR6 is required for IL-23-induced psoriasis-like inflammation in mice. J Clin Invest 119:2317-29
6. Kim H, Lee H, Chang Y-J, et al. (2014). IL-17 producing innate lymphoid cells and the NLRP3 inflammasome facilitate obesity-Associated airway hyperreactivity. Nat Med 20:54-61
7. Neill DR, Wong SH, Bellosi A, et al. (2010). Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity. Nature 464:1367-70
8. Pantelyushin S, Haak S, Ingold B, et al. (2012). Rorgammat+ innate lymphocytes and gammadelta T cells initiate psoriasiform plaque formation in mice. J Clin Invest 122:2252-6
9. Powell N, Walker AW, Stolarczyk E, et al. (2012). The transcription factor T-bet regulates intestinal inflammation mediated by interleukin-7 receptor+ innate lymphoid cells. Immunity 37:674-84
10. Salimi M, Barlow JL, Saunders SP, et al. (2013). A role for IL-25 and IL-33-driven type-2 innate lymphoid cells in atopic dermatitis. J Exp Med 210:2939-50
11. Sigurdardottir SL, Thorleifsdottir RH, Valdimarsson H, et al. (2013). The association of sore throat and psoriasis might be explained by histologically distinctive tonsils and increased expression of skin-homing molecules by tonsil T cells. Clin Exp Immunol 174:139-51
12. Teunissen M, Munneke M, Bernink J, et al. (2014). Composition of innate lymphoid cell subsets in the human skin: Enrichment of NCR+ ILC3 in lesional skin and blood of psoriasis patients. J Invest Dermatol 134:2351-60
13. Villanova F, Flutter B, Tosi I, et al. (2014). Characterization of innate lymphoid cells in human skin and blood demonstrates increase of NKp44+ ILC3 in psoriasis. J Invest Dermatol 134:984-91
14. Zaba LC, Suarez-Farinas M, Fuentes-Duculan J, et al. (2009). Effective treatment of psoriasis with etanercept is linked to suppression of IL-17 signaling, not immediate response TNF genes. J Allergy Clin Immunol 124:1022-30.